Jefferies Group LLC Sangamo Therapeutics, Inc Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$8.03 - $11.7 $408,887 - $595,764	-50,920 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$9.05 - $12.22 $460,826 - $622,242	50,920 New	50,920 $461,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $300,683 - $474,431	-18,005 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $208,858 - $312,386	18,005	18,005 $295,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.